Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Leukemia 53Leukemia, Myeloid, Acute 33Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma 27Lymphoma, Non-Hodgkin 22Myelodysplastic Syndromes 21Lymphoma, Follicular 21Lymphoma, Mantle-Cell 20Lymphoma, Large B-Cell, Diffuse 20Leukemia, Myeloid, Chronic-Phase 19Lymphoma, Large-Cell, Immunoblastic 18Burkitt Lymphoma 18Lymphoma, B-Cell, Marginal Zone 17Hodgkin Disease 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Congenital Abnormalities 15Multiple Myeloma 14Leukemia, Myeloid, Accelerated Phase 14Neoplasms, Plasma Cell 10Blast Crisis 10Myeloproliferative Disorders 9Leukemia, Monocytic, Acute 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myelomonocytic, Acute 8Anemia, Refractory, with Excess of Blasts 8Waldenstrom Macroglobulinemia 7Recurrence 7

Interventions

Melphalan 2sargramostim 1keyhole-limpet hemocyanin 1Transplantation 1FANG vaccine 1Cord Blood Stem Cell Transplantation 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Diseases, Inborn × sargramostim × Other hematologic neoplasm × Clear all
NCT00019097 2024-03-04

Vaccine Therapy in Treating Patients With Multiple Myeloma

National Cancer Institute (NCI)

Phase 2 Completed
Other hematologic neoplasmPlasma cell

Multiple Myeloma, Neoplasms, Hematologic Neoplasms, Genetic Diseases, Inborn, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡